Fig. 2.
a GO-specific quality-of-life questionnaire (GO-QOL) at 6 and 12 months in patients with mild GO treated with selenium, placebo, or pentoxifylline. b GO outcome at 6 and 12 months based on a composite ophthalmological score [40].
a GO-specific quality-of-life questionnaire (GO-QOL) at 6 and 12 months in patients with mild GO treated with selenium, placebo, or pentoxifylline. b GO outcome at 6 and 12 months based on a composite ophthalmological score [40].